Raymond James cuts Ionis Pharmaceuticals target price to $54 from $79
IONS•Raymond James cut its target price for Ionis Pharmaceuticals to $54 from $79.
Related News
Robotaxi wars will end in Uber-Waymo union
UBER•
CBA sees stubborn Australian inflation clouding interest rate outlook
TLT•
Federal Circuit hears appeal over Acadia's Nuplazid formulation patent
ACAD•
Australia's Qantas to axe 850 jobs in offshoring deal with Accenture
ACN•
Vistra target price raised to $178 from $176
VST•